Correction: Lipopolysaccharide-pretreated mesenchymal stem cell-conditioned medium optimized with 10 kDa filter attenuates the injury of H9c2 cardiomyocytes in a model of hypoxia/reoxygenation
Can J Physiol Pharmacol. 2022 Oct 21.
doi: 10.1139/cjpp-2022-0418.
Online ahead of print.
1 Department of Clinical Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China.
2 Department of Pharmacy, Ordos Central Hospital, Ordos, Inner Mongolia 017000, China.
3 Department of Clinical Laboratory, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China.
4 Department of Imaging & Pathology, Biomedical Sciences, Radiology, University Hospitals, KU Leuven O&N1, Herestraat 49, B-3000 Leuven, Belgium.
5 CAS Key Laboratory of Separation Science for Analytical Chemistry, National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian, Liaoning 116023, China.
6 Department of Echocardiography, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China.